Alicia K Morgans
Affiliation: Vanderbilt University
- Bone-targeted agents: preventing skeletal complications in prostate cancerAlicia K Morgans
Department of Hematology Oncology, Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA
Urol Clin North Am 39:533-46. 2012..ADT results in bone loss and fragility fractures. This review describes the biology of bone metastases, skeletal morbidity, and recent advances in bone-targeted therapies to prevent skeletal complications of prostate cancer...
- Bone density testing among prostate cancer survivors treated with androgen-deprivation therapyAlicia K Morgans
Division of Hematology and Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA
Cancer 119:863-70. 2013..Guidelines recommend bone density testing before and during ADT to characterize fracture risk. The authors of the current report assessed bone density testing among men who received ADT for ≥ 1 year...
- Racial differences in bone mineral density and fractures in men receiving androgen deprivation therapy for prostate cancerAlicia K Morgans
Massachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA
J Urol 187:889-93. 2012..Using data from a prospective clinical trial we compared bone mineral density and fracture between African-American and Caucasian men receiving androgen deprivation therapy...